Pfizer

Sanford-Burnham, Pfizer partner in drug discovery

Thursday, November 3, 2011 12:57 PM

Sanford-Burnham Medical Research Institute is the latest research organization to partner with Pfizer as part of Pfizer's commitment to transforming research and development through a focus on translational medicine. The Centers for Therapeutic Innovation (CTI) is a research unit at Pfizer dedicated to open innovation through establishing global partnerships with academic research institutions to bridge the gap between discovery science and clinical applications.

More... »

Caliper, Pfizer launch platform for drug safety

Thursday, November 3, 2011 09:02 AM

Caliper Life Sciences, a provider of tools and services for drug
discovery and life sciences research, has launched a new services
offering based on a panel of cellular assays that measure the effects of
drug candidates on functional activity of proteins called kinases involved
in critical cell-signaling pathways. The technology platform and initial
panel of nine assays were developed in collaboration with Pfizer. The new offering, called In-Cell KinaseScreen, is immediately available for compound screening, profiling, and custom assay development services for CDAS' clients, ranging from academia to pharmaceutical companies.

More... »

Survey: 80% of big pharma companies restructuring to strategically outsource more trials to CROs

Monday, October 31, 2011 08:00 AM

According to a recent survey from William Blair, about 80% of big pharma companies either are in the process of restructuring or have already completed restructuring plans to strategically outsource more of their trials to CROs.

More... »

Pfizer signs precision medicine research agreement with Medco

Thursday, October 27, 2011 01:41 PM

Pfizer has established a research collaboration with Medco Health Solutions and its wholly owned subsidiary, United BioSource Corporation (UBC), aimed at more effectively matching patients with treatments that will benefit them the most, thereby improving patient outcomes.

More... »

deCODE, Pfizer ink research agreement

Thursday, October 13, 2011 10:45 AM

deCODE genetics has entered into a research collaboration with Pfizer to discover sequence variants associated with specific clinical phenotypes related to Systemic Lupus Erythematosis.

More... »

Exonhit, Pfizer collaborate in Alzheimer’s research

Tuesday, October 11, 2011 02:26 PM

Exonhit has entered into a research agreement with Pfizer for the identification of new Alzheimer's disease biomarkers using Exonhit's Genome-Wide SpliceArray (GWSA) platform.

More... »

Puma Biotech, Pfizer ink licensing agreement for Nertatinib

Thursday, October 6, 2011 01:01 PM

Puma Biotechnology, has signed an agreement with Pfizer to license the worldwide commercial rights to neratinib, a potent, irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4) kinases.  Neratinib is being studied in the neoadjuvant, adjuvant and metastatic settings in patients with HER2/ErbB2 positive breast cancer.

More... »

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

Pfizer to cut 220 jobs in Spain

Thursday, September 22, 2011 11:41 AM

Pfizer has unveiled plans to cut its workforce in Spain by 11%, or 220 staff, driven by the financial crisis in Europe and regulatory moves in the country to reduce its healthcare spend, according to PharmaTimes.

More... »

Pfizer to invest $200 million in Irish facility

Tuesday, September 20, 2011 01:33 PM

Pfizer has announced that it is to invest $200 million at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co Dublin, according to PharmaTimes.

More... »